Contact this trialFirst, we need to learn more about you.
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor
Dapagliflozin +1 More for Type 2 Diabetes
Recruiting2 awardsPhase 3
Marrero, Louisiana
This trial will compare the safety and effectiveness of orforglipron and dapagliflozin in helping people with type 2 diabetes control their blood sugar levels. The trial will last for about
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.